EP3434686A4 - PROCESS FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTETIC HORMONES, RECOMBINANT HYBRID OR NON-HYBRID GLYCOPROTETIC HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTETIC HORMONES - Google Patents

PROCESS FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTETIC HORMONES, RECOMBINANT HYBRID OR NON-HYBRID GLYCOPROTETIC HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTETIC HORMONES Download PDF

Info

Publication number
EP3434686A4
EP3434686A4 EP16894820.6A EP16894820A EP3434686A4 EP 3434686 A4 EP3434686 A4 EP 3434686A4 EP 16894820 A EP16894820 A EP 16894820A EP 3434686 A4 EP3434686 A4 EP 3434686A4
Authority
EP
European Patent Office
Prior art keywords
hybrid
glycoprotetic
hormones
recombinant
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16894820.6A
Other languages
German (de)
French (fr)
Other versions
EP3434686A1 (en
EP3434686C0 (en
EP3434686B1 (en
Inventor
Marcelo Dias Baruffi
Camillo del Cistia ANDRADE
Rubens Eduardo da SILVA
Robinson Antonio Martins de OLIVEIRA
Daniel Roberto CALLEJON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lcr Kimera Biotecnologia Ltda - Me
Universidade de Sao Paulo USP
Original Assignee
Lcr Kimera Biotecnologia Ltda - Me
Universidade de Sao Paulo USP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102016006222-5A external-priority patent/BR102016006222B1/en
Application filed by Lcr Kimera Biotecnologia Ltda - Me, Universidade de Sao Paulo USP filed Critical Lcr Kimera Biotecnologia Ltda - Me
Publication of EP3434686A1 publication Critical patent/EP3434686A1/en
Publication of EP3434686A4 publication Critical patent/EP3434686A4/en
Application granted granted Critical
Publication of EP3434686C0 publication Critical patent/EP3434686C0/en
Publication of EP3434686B1 publication Critical patent/EP3434686B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP16894820.6A 2016-03-22 2016-05-10 Method for producing and purifying hybrid or non-hybrid recombinant glycoprotein hormones, hybrid or non-hybrid recombinant glycoprotein hormones, expression vectors and uses of the recombinant glycoprotein hormones Active EP3434686B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102016006222-5A BR102016006222B1 (en) 2016-03-22 Hybrid recombinant glycoprotein hormones, production and purification process, and their uses.
PCT/BR2016/000051 WO2017161427A1 (en) 2016-03-22 2016-05-10 Method for producing and purifying hybrid or non-hybrid recombinant glycoprotein hormones, hybrid or non-hybrid recombinant glycoprotein hormones, expression vectors and uses of the recombinant glycoprotein hormones

Publications (4)

Publication Number Publication Date
EP3434686A1 EP3434686A1 (en) 2019-01-30
EP3434686A4 true EP3434686A4 (en) 2019-04-10
EP3434686C0 EP3434686C0 (en) 2025-10-01
EP3434686B1 EP3434686B1 (en) 2025-10-01

Family

ID=59914222

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16894820.6A Active EP3434686B1 (en) 2016-03-22 2016-05-10 Method for producing and purifying hybrid or non-hybrid recombinant glycoprotein hormones, hybrid or non-hybrid recombinant glycoprotein hormones, expression vectors and uses of the recombinant glycoprotein hormones

Country Status (3)

Country Link
US (1) US20220267401A1 (en)
EP (1) EP3434686B1 (en)
WO (1) WO2017161427A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3398609A4 (en) * 2015-12-28 2019-05-08 Ouro Fino Saúde Animal Participações S.A. PROCESS FOR THE PRODUCTION OF RECOMBINANT EQUINE CHORIONIC CHRONIC GONADOTROPHIN (RECG), VETERINARY COMPOSITION AND USE
WO2020084034A1 (en) 2018-10-26 2020-04-30 F. Hoffmann-La Roche Ag Multispecific antibody screening method using recombinase mediated cassette exchange
BR102019004147A2 (en) * 2019-02-28 2020-10-06 Ouro Fino Saude Animal Participacoes S.A. BIOLOGICALLY ACTIVE CHORINONIC CHORINIC GONADOTROPHINE (RECG) AND PROCESS TO OBTAIN THE SAME, VETERINARY COMPOSITION AND USE
CN109975264B (en) * 2019-04-18 2022-04-08 安徽农业大学 Method for researching gene function of lentivirus transfected blastocyst trophoblast cells
JP7555398B2 (en) * 2019-08-30 2024-09-24 シンテックス エス．エー． Recombinant chorionic gonadotropin, methods for its preparation, pharmaceutical compositions and uses
AR117743A1 (en) * 2019-12-30 2021-08-25 Univ Nacional Del Litoral Unl METHOD OF OBTAINING A MAMMALIAN CELL LINE THAT EXPRESSES A RECOMBINANT EQUINE CHORIONIC GONADOTROPHIN HORMONE (reCG), CELL LINE THAT EXPRESSES reCG, PRODUCTION METHOD AT A SCALE OF reCG, reCGS, AND CODES THAT USE THE NORMS FOR THE USE OF RECOMBINES, RECGS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012131306A1 (en) * 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
WO2015124945A1 (en) * 2014-02-21 2015-08-27 Arcis Biotechnology Holdings Limited Permeability and transformation of cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502525A (en) * 1988-09-01 1991-06-13 アプライド・リサーチ・システムス・エー・アール・エス・ホールディング・エヌ・ブイ A method for producing a gonadotropin and TSH superagonist, and a superagonist produced by the method
ES2210307T3 (en) * 1994-08-12 2004-07-01 Washington University MONOCATENARY FORMS OF THE GLICOPROTEINIC HORMONE QUARTET.
AU4964197A (en) * 1996-11-12 1998-06-03 Teikoku Hormone Mfg. Co., Ltd. Recombinant single-stranded equine chorionic gonadotropin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012131306A1 (en) * 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
WO2015124945A1 (en) * 2014-02-21 2015-08-27 Arcis Biotechnology Holdings Limited Permeability and transformation of cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
S�BASTIEN LEGARDINIER ET AL: "Stability and biological activities of heterodimeric and single-chain equine LH/chorionic gonadotropin variants", JOURNAL OF MOLECULAR ENDOCRINOLOGY., vol. 40, no. 4, 15 February 2008 (2008-02-15), GB, pages 185 - 198, XP055557280, ISSN: 0952-5041, DOI: 10.1677/JME-07-0151 *
See also references of WO2017161427A1 *

Also Published As

Publication number Publication date
EP3434686A1 (en) 2019-01-30
BR102016006222A2 (en) 2017-09-26
EP3434686C0 (en) 2025-10-01
US20220267401A1 (en) 2022-08-25
WO2017161427A1 (en) 2017-09-28
EP3434686B1 (en) 2025-10-01

Similar Documents

Publication Publication Date Title
EP3434686A4 (en) PROCESS FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTETIC HORMONES, RECOMBINANT HYBRID OR NON-HYBRID GLYCOPROTETIC HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTETIC HORMONES
EP3318548A4 (en) PROCESS FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN AND PROCESS FOR PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPENE
EP3372627A4 (en) PROCESS FOR PRODUCING THERMOPLASTIC RESIN
EP3437493A4 (en) PROCESS FOR PRODUCING AROMA SOURCE
EP3421506A4 (en) SUPPORTED CATALYST OF METALLOCENE TYPE AND PROCESS FOR PRODUCTION OF POLYPROPYLENE USING THE SAME
EP3527609A4 (en) PROCESS FOR THE PRODUCTION OF POLYHYDROXYALKANOIC ACID
EP3604367A4 (en) SEQUENCED COPOLYMER AND PROCESS FOR THE PRODUCTION OF SEQUENCED COPOLYMER
EP3395860A4 (en) PROCESS FOR PRODUCING POLYMER AGGREGATE
EP3404056A4 (en) PROCESS FOR PRODUCING THERMOPLASTIC ELASTOMER COMPOSITION
EP3323856A4 (en) STRETCH FILM, PROCESS FOR PRODUCING STRETCH FILM, AND POLYAMIDE RESIN COMPOSITION
EP3578536A4 (en) FLUOROHALOGENATED HYDROCARBON PRODUCTION PROCESS
EP3388390A4 (en) PROCESS FOR PRODUCING OZONE
EP3296282A4 (en) PROCESS FOR PRODUCING HYDROHALOFLUOROOLEFINS
EP3327066A4 (en) PROCESS FOR PRODUCING COAGULATED ARTICLE
EP3527593A4 (en) ISOCYANATE COMPOSITION, PROCESS FOR PRODUCING ISOCYANATE COMPOSITION, AND PROCESS FOR PRODUCING ISOCYANATE POLYMER
EP3630738A4 (en) OZANIMOD PRODUCTION PROCESS
EP3366776A4 (en) RECOMBINANT MICROORGANISM FOR THE PRODUCTION OF L-THREONIN AND PROCESS FOR PRODUCING L-THREONIN USING THE SAME
EP3395896A4 (en) POLYLACTIC ACID RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME
EP2837640A4 (en) PROCESS FOR PRODUCING POLYOLEFIN POLYMERIZATION CATALYST AND PROCESS FOR PREPARING POLYOLEFIN
EP3535302A4 (en) PROCESS FOR PRODUCING MODIFIED DIENE RUBBER, RUBBER, AND COMPOSITION THEREOF
EP3393267A4 (en) PROCESS FOR PRODUCING SEMEN SUSPENSION
EP2921474A4 (en) SEMICARBAZIDE COMPOSITION, PROCESS FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS RESIN COMPOSITION, AND COMPOSITE
EP2963088A4 (en) CURABLE COMPOSITION, CURED PRODUCT, PROCESS FOR USING THE CURABLE COMPOSITION, SEALING BODY FOR PHOTOELEMENTS AND METHOD FOR PRODUCING THE SAME
EP3392307A4 (en) PROCESS FOR PRODUCING POLYACETAL RESIN COMPOSITION
EP3305822A4 (en) PROCESS FOR PRODUCTION OF THERMOPLASTIC ELASTOMER, AND THERMOPLASTIC ELASTOMER

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181016

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20190313

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/74 20060101ALI20190306BHEP

Ipc: A61K 38/24 20060101ALI20190306BHEP

Ipc: C12N 15/16 20060101ALI20190306BHEP

Ipc: G01N 33/76 20060101ALI20190306BHEP

Ipc: A61P 15/08 20060101ALI20190306BHEP

Ipc: C07K 14/59 20060101AFI20190306BHEP

Ipc: C12N 15/66 20060101ALI20190306BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201207

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20231018

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250509

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Ref country code: CH

Ref legal event code: F10

Free format text: ST27 STATUS EVENT CODE: U-0-0-F10-F00 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20251001

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20251008

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

Effective date: 20251014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251001

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20260101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251001

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20260101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20260201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251001

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20251001